Literature DB >> 3005406

Interferon-gamma-induced IA expression in WEHI-3 cells is enhanced by the presence of 1,25-dihydroxyvitamin D3.

P A Morel, S C Manolagas, D M Provvedini, D R Wegmann, J M Chiller.   

Abstract

It has been suggested recently that 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] is involved in the regulation of the immune functions of lymphocytes and in the differentiation of monocytic cells. This report examined the possibility that 1,25(OH)2D3 influences immune functions mediated by monocytic cells by studying its effect on the murine myelomonocytic line WEHI-3. We found that WEHI-3 cells possess 3.3S receptor proteins with high affinity (Kd = 3.3 X 10(-10) M) for 1,25(OH)2D3 that are capable of binding to DNA. Also we found that 1,25(OH)2D3 enhances the interferon-gamma (IFN-gamma)-induced expression of the class II major histocompatibility complex antigens (Ia molecules), and such enhancement leads to increased capacity of the WEHI-3 cells to stimulate antigen-specific Ia-restricted T cell activation. Finally, 1,25(OH)2D3 inhibits the proliferation of WEHI-3 cells, and this inhibition is enhanced in the presence of IFN-gamma. The 1,25(OH)2D3 modulation of IFN-gamma induction of Ia antigens suggests that the hormone might promote monocytes to function more efficiently as antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005406

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Effects of 1 alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U937 cells: role in cell differentiation, activation and phagocytosis.

Authors:  A Spittler; M Willheim; F Leutmezer; R Ohler; W Krugluger; C Reissner; T Lucas; T Brodowicz; E Roth; G Boltz-Nitulescu
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

2.  Increased contact hypersensitivity response in mice by topical application of 1 alpha,25-dihydroxyvitamin D3 to elicitation site.

Authors:  M Tani; Y Murata; S Harada; T Takashima; T Horikawa
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

3.  Constitutive and inducible expression of HLA class II determinants by human osteoblast-like cells in vitro.

Authors:  H Skjødt; D E Hughes; P R Dobson; R G Russell
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

4.  Increased expression of major histocompatibility complex antigens on lymphocytes from aged mice.

Authors:  C L Sidman; E A Luther; J D Marshall; K A Nguyen; D C Roopenian; S M Worthen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  1,25-Dihydroxyvitamin D3 down-regulation of HLA-DR on human peripheral blood monocytes.

Authors:  N Tokuda; N Mizuki; M Kasahara; R B Levy
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

6.  Antibody- and complement-dependent cell injury assayed by 51Cr release from human peripheral blood mononuclear cells pretreated with lipopolysaccharide.

Authors:  H Repo; M Leirisalo-Repo; M Nurminen; P H Mäkelä
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  1,25-Dihydroxyvitamin D3, but not retinoic acid, induces the differentiation of U937 cells.

Authors:  A K Bhalla; M M Williams; S Lal; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

8.  Correlation of T cell receptor V beta gene family with MHC restriction.

Authors:  P A Morel; A M Livingstone; C G Fathman
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

9.  The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua.

Authors:  Daniel Zehnder; Katie N Evans; Mark D Kilby; Judith N Bulmer; Barbara A Innes; Paul M Stewart; Martin Hewison
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

10.  Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients.

Authors:  Masanori Atsukawa; Akihito Tsubota; Noritomo Shimada; Kai Yoshizawa; Hiroshi Abe; Toru Asano; Yusuke Ohkubo; Masahiro Araki; Tadashi Ikegami; Chisa Kondo; Norio Itokawa; Ai Nakagawa; Taeang Arai; Yoko Matsushita; Katsuhisa Nakatsuka; Tomomi Furihata; Yoshimichi Chuganji; Yasushi Matsuzaki; Yoshio Aizawa; Katsuhiko Iwakiri
Journal:  BMC Infect Dis       Date:  2015-08-19       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.